Latest news

Intravacc to in-license CimCure’s iBoost technology, expanding its vaccine platform portfolio

CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]

News

Alumni Joint Master Entrepreneurship (UvA/VU) often pursue entrepreneurial careers

An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]

News

2016 AMSIA winner receives CE Mark for non-radioactive tumor localization system

MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]

News

Demonstrator Lab: news and updates

Demonstrator Lab is an entrepreneurship laboratory, a learning-by-doing environment where students and staff of HvA, UvA, VU and Amsterdam UMC have the opportunity to test and transform ideas into tangible products or services. Demonstrator Lab is located at Vrije Universiteit Amsterdam and is part of the IXAnext valorization program. For those who have successfully started […]

News

Researchers and staff collaborate in Amsterdam UMC COVID-19 Task Force

Over a short time period, the Coronavirus outbreak has profoundly affected the daily practice of Amsterdam UMC staff. Many promising initiatives have shown an enormous adaptive power, creativity and perseverance of the Amsterdam UMC personnel. Not only doctors, nurses and supporting staff have worked around the clock to provide the best care for patients, researchers […]

News

Physics2Market valorization grants also open for COVID-19 projects

The IXAnext Physics2Market funding instrument, a seed funding to kick-start collaboration with industry on subjects in physics, is now also inviting initiatives contributing to the current COVID-19 pandemic.  The Physics2Market grant not only provides funding on subjects in physics but also  in the physical sciences in the broader sense. The maximum funding is € 35,000 […]

News

Coronavirus: the importance of ventilation

Using laser light techniques, UvA physicists and medical researchers have found that small cough droplets, potentially containing virus particles, can float in the air in a room for many minutes, especially when the room is poorly ventilated. Good ventilation in public spaces (e.g. public transport, nursing homes) is therefore crucial to slow down the spread […]

News

Geld van Innovatiefonds NH voor 3D printen op micron schaal

Photosynthetic B.V., een startup gevestigd in Amsterdam, heeft een converteerbare lening van € 300.000 ontvangen van het Innovatiefonds Noord-Holland. Met deze financiering ontwikkelt het bedrijf een technologie om op micron schaal 3D structuren te printen. De technologie van Photosynthetic maakt het mogelijk om 3D structuren te printen op micron niveau. Toepassingen waar 3D printen op […]

News

Onderzoekers passen nieuwe meettechnieken toe om barsten in oude schilderijen te begrijpen

Om meer te weten te komen over het ontstaan van scheurtjes in verflagen, hebben onderzoekers van Het Rijksmuseum gebruik gemaakt van een nieuwe meetmethode gebaseerd op technieken uit de biomedische en natuurwetenschappen, in samenwerking met onderzoekers van de Vrije Universiteit Amsterdam. Met de resultaten beoogt het multidisciplinaire team onder meer bij te kunnen dragen aan […]

News

Lava and Janssen announces collaboration to develop bi-specific gamma-delta T-cell engager therapeutics

Lava Therapeutics B.V. (spin-off Amsterdam UMC, location VUmc) announced that it has entered into a research and license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover and develop novel bispecific antibodies to gamma-delta T cells for the treatment of cancer. The collaboration was facilitated by Johnson […]

News